文献速递心境障碍焦虑、强迫与应激相关障碍

心理健康智能手机应用对抑郁和焦虑症状疗效的更新Meta分析

Current evidence on the efficacy of mental health smartphone apps for symptoms of depression and anxiety. A meta-analysis of 176 randomized controlled trials.
PubMed 文献 · World Psychiatry · 2024-01-01

该更新Meta分析纳入176项RCT,评估智能手机应用对抑郁和焦虑症状的疗效。应用对抑郁症状(g=0.28)和广泛性焦虑症状(g=0.26)有整体显著但较小的效应,且效应在不同随访点及排除小样本和高偏倚风险试验后稳健。应用纳入CBT特征或聊天机器人技术时抑郁效应更大,焦虑效应在CBT应用或含情绪监测功能时更大。

要点

  • 应用对抑郁症状效应量g=0.28,NNT=11.5;对广泛性焦虑g=0.26,NNT=12.4。
  • CBT特征或聊天机器人技术可增大抑郁效应,CBT或情绪监测可增大焦虑效应。
  • 社交焦虑g=0.52、强迫症状g=0.51、创伤后应激g=0.12、恐高症g=0.90,但证据质量需谨慎解读。

核心结论

  • 智能手机应用对抑郁和广泛性焦虑症状有整体显著但较小的效应,特定应用特征与更大效应量相关。

研究设计与样本

  • 更新Meta分析纳入176项旨在治疗抑郁或焦虑症状的随机对照试验(RCT)。

主要发现

  • 应用对抑郁症状效应量g=0.28(N=33,567,p<0.001,NNT=11.5),对广泛性焦虑g=0.26(N=22,394,p<0.001,NNT=12.4)。
  • 抑郁症状方差比RoV=-0.14(95%CI:-0.24至-0.05),广泛性焦虑RoV=-0.21(95%CI:-0.31至-0.12)。
  • 社交焦虑g=0.52、强迫症状g=0.51、创伤后应激g=0.12、恐高症g=0.90、惊恐症状g=-0.12(不显著)。

关键数值与推荐

  • 应用纳入认知行为疗法(CBT)特征或聊天机器人技术时抑郁效应量显著更大。
  • 焦虑效应量在广泛性焦虑为主要靶点时显著更大,CBT应用或含情绪监测功能的应用亦增大效应。

临床怎么用

  • 智能手机应用可作为抑郁和广泛性焦虑的 scalable 辅助治疗工具,优先选择含CBT或情绪监测功能的应用。
  • 对社交焦虑和强迫症状可考虑应用干预,但需注意证据多来自高偏倚风险和小样本试验。

局限性

  • 社交焦虑、强迫、创伤后应激、恐高症和惊恐症状的结果需谨慎解读,因多数试验高偏倚风险且样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The mental health care available for depression and anxiety has recently undergone a major technological revolution, with growing interest towards the potential of smartphone apps as a scalable tool to treat these conditions. Since the last comprehensive meta-analysis in 2019 established positive yet variable effects of apps on depressive and anxiety symptoms, more than 100 new randomized controlled trials (RCTs) have been carried out. We conducted an updated meta-analysis with the objectives of providing more precise estimates of effects, quantifying generalizability from this evidence base, and understanding whether major app and trial characteristics moderate effect sizes. We included 176 RCTs that aimed to treat depressive or anxiety symptoms. Apps had overall significant although small effects on symptoms of depression (N=33,567, g=0.28, p<0.001; number needed to treat, NNT=11.5) and generalized anxiety (N=22,394, g=0.26, p<0.001, NNT=12.4) as compared to control groups. These effects were robust at different follow-ups and after removing small sample and higher risk of bias trials. There was less variability in outcome scores at post-test in app compared to control conditions (ratio of variance, RoV=-0.14, 95% CI: -0.24 to -0.05 for depressive symptoms; RoV=-0.21, 95% CI: -0.31 to -0.12 for generalized anxiety symptoms). Effect sizes for depression were significantly larger when apps incorporated cognitive behavioral therapy (CBT) features or included chatbot technology. Effect sizes for anxiety were significantly larger when trials had generalized anxiety as a primary target and administered a CBT app or an app with mood monitoring features. We found evidence of moderate effects of apps on social anxiety (g=0.52) and obsessive-compulsive (g=0.51) symptoms, a small effect on post-traumatic stress symptoms (g=0.12), a large effect on acrophobia symptoms (g=0.90), and a non-significant negative effect on panic symptoms (g=-0.12), although these results should be considered with caution, because most trials had high risk of bias and were based on small sample sizes. We conclude that apps have overall small but significant effects on symptoms of depression and generalized anxiety, and that specific features of apps - such as CBT or mood monitoring features and chatbot technology - are associated with larger effect sizes.

来源:World Psychiatry,查看原文。版权归原作者所有。

引用

  1. Linardon J, Torous J, Firth J, et al. Current evidence on the efficacy of mental health smartphone apps for symptoms of depression and anxiety. A meta-analysis of 176 randomized controlled trials. World Psychiatry. 2024. PMID: 38214614. doi:10.1002/wps.21183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。